Kevin J. Duffy - Concepedia

Author

Kevin J. Duffy

Also Known As

Duffy, K.J., K. Duffy, K. J. DUFFY, K. J. Duffy, K.J. Duffy, KEVIN J. DUFFY, Kevin Duffy, Kevin J Duffy, Kevin J. Duffy, Kevin J. Duffy

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)Ligand Pharmaceuticals (United States)South College Ono Pharmaceutical (United Kingdom)GlaxoSmithKline (United Kingdom)

About

Kevin J. Duffy is an author at GlaxoSmithKline (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	2.7K
2	Natural Sciences	9	9	605
3	Biochemistry	7	7	380
4	Engineering	2	2	168
5	Public Health	1	1	14

Kevin J. Duffy

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Design of amidobenzimidazole STING receptor agonists with systemic activity Joshi M. Ramanjulu, G. Scott Pesiridis, Jingsong Yang, Nature Systemic ActivityMedicineMechanism Of ActionPharmacological AgentPharmacotherapy	2018	803
Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells Han Xie, Jun‐ichi Hanai, Jian-Guo Ren, Cell Metabolism OncologyOncogenic AgentImpacts Tumor-initiating CellsMedicineMouse Models	2014	507
Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist Connie L. Erickson‐Miller, Evelyne Delorme, Shin‐Shay Tian, Stem Cells Platelet NumbersImmunologyBlood CellIncreased Platelet ProductionPharmacotherapy	2008	280
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies Harriet S. Walter, Simon A. Rule, Martin J.S. Dyer, Blood	2015	262
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells Julia Billiard, Jennifer B. Dennison, Jacques Briand, Cancer & Metabolism	2013	231
Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist Connie L. Erickson‐Miller, Evelyne Delorme, Shin‐Shay Tian, Experimental Hematology ThrombopoiesisThrombosisSignal TransductionFunctional SelectivityMedicine	2005	202
Identification and Biological Characterization of Heterocyclic Inhibitors of the Hepatitis C Virus RNA-dependent RNA Polymerase Dashyant Dhanak, Kevin J. Duffy, Victor K. Johnston, Journal of Biological Chemistry	2002	196
Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury Pinelopi P. Kapitsinou, Hideto Sano, Mark Michael, Journal of Clinical Investigation Acute Lung InjuryIschemia ReperfusionRenal PathologyImmunologyRenal Inflammation	2014	180
3-(1,1-Dioxo-2<i>H</i>-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1<i>H</i>)-quinolinones, Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Rosanna Tedesco, Antony N. Shaw, Ramesh Bambal, Journal of Medicinal Chemistry	2006	159
Total Synthesis of Altohyrtin A (Spongistatin 1): Part 1 Jiasheng Guo, Kevin J. Duffy, Kirk L. Stevens, Angewandte Chemie International Edition BiologyBiosynthesisBioorganic ChemistryMarine BiotechnologyMarine Sponges	1998	128

Page 1